[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355043-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355043-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-of-novel-exosomal-mirnasand-their-role-in-diagnosis-and-prognosis-of-triple-negative-breast-cancer","Identification of novel exosomal miRNAsand their role in diagnosis and prognosis of triple negative breast cancer","","Triple-negative breast cancer (TNBC) is an aggressive subtype with poor prognosis and limited treatment options. Exosomal microRNAs (miRNAs) are investigated as non-invasive biomarkers for cancer detection and disease monitoring. The study identifies five exosomal miRNAs (hsa-miR-6803, hsa-miR-1180, hsa-miR-4728, hsa-miR-1915, hsa-miR-940) overexpressed in TNBC cells, stem-like subpopulations, and tumor tissues. Meta-analysis and in-vitro validation link higher expression to worse overall survival, while functional assays show hsa-miR-1180 and hsa-miR-4728 promote migration and invasion. ",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-of-novel-exosomal-mirnasand-their-role-in-diagnosis-and-prognosis-of-triple-negative-breast-cancer/355043/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-of-novel-exosomal-mirnasand-their-role-in-diagnosis-and-prognosis-of-triple-negative-breast-cancer/355043.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are exosomal microRNAs considered useful for TNBC diagnostics and monitoring?","Question",{"text":63,"@type":64},"Exosomal miRNAs are packaged in secretory vesicles and remain stable in circulation, allowing them to reflect tumor-related molecular features for non-invasive biomarker applications.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which five exosomal miRNAs were identified as consistently overexpressed in TNBC?",{"text":68,"@type":64},"The study reports overexpression of hsa-miR-6803, hsa-miR-1180, hsa-miR-4728, hsa-miR-1915, and hsa-miR-940 in TNBC cells, stem-like subpopulations, and patient tumor tissues.",{"name":70,"@type":61,"acceptedAnswer":71},"How do hsa-miR-1180 and hsa-miR-4728 affect TNBC cell behavior?",{"text":72,"@type":64},"Functional assays indicate that hsa-miR-1180 and hsa-miR-4728 enhance TNBC cell migration and invasion, suggesting involvement in oncogenic pathways.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355043,1790173095,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Choudhary et al. BMC Cancer (2026) 26:210 [https://doi.org/10.1186/s12885-025-15499-6](https://doi.org/10.1186/s12885-025-15499-6)  \nBMC Cancer  \nRESEARCH Open Access  \nIdentification of novel exosomal miRNAsand their role in diagnosis and prognosis of triple negative breast cancer  \nAnanya Choudhary1, Satish S. Poojary 1, Priyanka Jain1, Harit Chaturvedi2 and Bhudev C. Das 1*  \nAbstract  \nTriple-negative breast cancer (TNBC) is a clinically aggressive subtype characterized by poor prognosis and limited therapeutic options. Exosomal microRNAs (miRNAs), enclosed within secretory vesicles, have emerged as promising non-invasive biomarkers for cancer detection and disease monitoring. In this study, we identify a panel of five exosomal miRNAs: hsa-miR-6803, hsa-miR-1180, hsa-miR-4728, hsa-miR-1915, and hsa-miR-940, that are consistently overexpressed in TNBC cells, stem-like subpopulations, and patient tumor tissues. Integrated meta-analysis of public datasets combined with in-vitro validation revealed that elevated expression of these miRNAs correlates with poor overall survival. Functional assays further demonstrated that hsa-miR-1180 and hsa-miR-4728 enhance TNBC cell migration and invasion, implicating them in key oncogenic pathways such as Wnt, Notch, and EGFR. The consistent enrichment of these miRNAs in exosomes underscores their potential as exploratory biomarkers for future  \nliquid-biopsy–based applications. To our knowledge, this discovery-phase investigation is the first to associate this exosomal miRNA panel with TNBC and its stem-like subpopulations, providing a preliminary framework for subsequent mechanistic and translational validation.  \nKeywords TNBC, MiRNA, Extracellular vesicles, Exosomes, CSC, Prognosis  \nIntroduction  \nTriple-negative breast cancer (TNBC) constitutes a highly aggressive and therapeutically challenging subtype of breast cancer, accounting for approximately 15–20% of all cases [1–3]. Lacking expression of estrogen receptor (ER), progesterone receptor (PR), and HER2, TNBC isnot amenable to endocrine or HER2-targeted therapies. As a result, treatment relies heavily on chemotherapy, which, despite initial effectiveness, is often followed by  \n*Correspondence: Bhudev C. Das [bcdas@amity.edu](bcdas@amity.edu)  \n1Amity Institute of Molecular Medicine and Stem Cell Research, Amity University Noida, Noida, Uttar Pradesh, India  \n2Max Institute of Cancer Care, Max Super Specialty Hospital, Saket, New Delhi, India  \nearly recurrence, rapid disease progression, and poor overall survival [2, 3]. The absence of molecularly defined targets has driven an urgent need to discover novel biomarkers that can enable early detection, stratify risk, and identify new avenues for intervention.  \nWithin the TNBC landscape, cancer stem-like cells (CSCs) have been implicated as key contributors to treatment resistance, disease persistence, and metastatic relapse. These cells exhibit self-renewal, phenotypic plasticity, and the ability to evade cytotoxic therapies [4, 5]. Their survival following treatment may underlie minimal residual disease and tumor recurrence, making CSCs a critical focus for next-generation diagnostics and effective therapeutic strategies [6].  \nExosome-derived microRNAs (miRNAs) have emerged as promising candidates for non-invasive biomarker  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless","cbCaijkQ47ftLAsd","https://ap.wps.com/l/cbCaijkQ47ftLAsd","pdf",3197502,21,"English","# Abstract\n# Keywords\n# Introduction\n# Materials and methods","[{\"question\":\"Why are exosomal microRNAs considered useful for TNBC diagnostics and monitoring?\",\"answer\":\"Exosomal miRNAs are packaged in secretory vesicles and remain stable in circulation, allowing them to reflect tumor-related molecular features for non-invasive biomarker applications.\"},{\"question\":\"Which five exosomal miRNAs were identified as consistently overexpressed in TNBC?\",\"answer\":\"The study reports overexpression of hsa-miR-6803, hsa-miR-1180, hsa-miR-4728, hsa-miR-1915, and hsa-miR-940 in TNBC cells, stem-like subpopulations, and patient tumor tissues.\"},{\"question\":\"How do hsa-miR-1180 and hsa-miR-4728 affect TNBC cell behavior?\",\"answer\":\"Functional assays indicate that hsa-miR-1180 and hsa-miR-4728 enhance TNBC cell migration and invasion, suggesting involvement in oncogenic pathways.\"}]","Identification of novel exosomal miRNAsand their role in diagnosis and prognosis of triple negative breast cancer | PDF",1790115552,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6047d02800c15af31197e3cfac9ce2d7.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d9da9232a213a8d78c3357029ea5108.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5041a8e536d2984d0c86abad766ac89.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d92e21f398ff2249642fcc25c6e7e798.webp",980,1306]